Helen of Troy Ltd
F:HT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
C
|
Creative Technology Ltd
XMUN:CTL
|
SG |
|
K
|
Keurig Dr Pepper Inc
F:DP5
|
US |
|
T
|
Tyler Technologies Inc
F:TYP
|
US |
|
Leonteq AG
F:EFL
|
CH |
|
B
|
Biotest AG
OTC:BIESF
|
DE |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
Wall St Price Targets
HT2 Price Targets Summary
Helen of Troy Ltd
According to Wall Street analysts, the average 1-year price target for HT2 is 16.46 EUR with a low forecast of 4.8 EUR and a high forecast of 28.54 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HT2's stock price target?
Price Target
16.46
EUR
According to Wall Street analysts, the average 1-year price target for HT2 is 16.46 EUR with a low forecast of 4.8 EUR and a high forecast of 28.54 EUR.
What is the Revenue forecast for Helen of Troy Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is -1%.
What is the Operating Income forecast for Helen of Troy Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is -5%.
What is the Net Income forecast for Helen of Troy Ltd?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is -9%.
